nitration, halogenation, and cyanation.1 For example, consider-
able efforts have been reported recently in the conversion of
the N-oxides into (a) 2-aminopyridine with Ts2O-tBuNH2
followed by in situ deprotection with TFA,5 (b) 2-aminopyridine
amides with imidoyl chlorides,6 (c) tetrazolopyridines with
sulfonyl or phosphoryl azides7 and imidazolopyridines with
sulfuryl diimidazole,8 (d) 2-alkyl, alkynyl, and arylpyridines
with Grignard reagents,9 and (e) 3-(2-hydroxyaryl)pyridines with
arynes.10 It is noteworthy that pyridine N-oxides also served as
an ideal choice to direct C-H functionalization of the pyridine
ring.11 Currently the pyridine N-oxides preparation is mainly
focused on the oxidation of corresponding pyridine analogues.
To this end, an alternative approach was described herein to
prepare the pyridine N-oxide derivatives via direct functional-
ization without deoxygenation.
Magnesiation of Pyridine N-Oxides via Iodine or
Bromine-Magnesium Exchange: A Useful Tool
for Functionalizing Pyridine N-Oxides
Xin-Fang Duan,* Zi-Qian Ma, Fang Zhang, and
Zhan-Bin Zhang
Department of Chemistry, Beijing Normal UniVersity,
Beijing, 100875, China
xinfangduan@Vip.163.com
ReceiVed September 29, 2008
Metalation of substituted pyridines has been well investi-
gated;12 however, only limited examples were reported regarding
the metalation of pyridine N-oxides, through either lithium or
zinc reagents.13,14 One of the challenges in lithiation with use
of n-BuLi, LDA, or LTMP is unwanted deprotonation of the
side chain if it is present at the pyridine N-oxide 2- or
(4) (a) Balzarini, J.; Keyaerts, E.; Vijgen, L.; Vandermeer, F.; Stevens, M.;
Clercq, E. D.; Egberink, H.; Ranst, M. V. J. Antimicrob. Chemother. 2006, 57,
472. (b) Stevens, M.; Pannecouque, C.; Clercq, E. D.; Balzarini, J. Biochem.
Pharmacol. 2006, 71, 1122. (c) Balzarini, J.; Stevens, M.; Clercq, E. D.; Schols,
D.; Pannecouque, C. J. Antimicrob. Chemother. 2005, 55, 135. (d) Haginoya,
N.; Kobayashi, S.; Komoriya, S.; Yoshino, T.; Nagata, T.; Hirokawab, Y.;
Nagaharab, T. Bioorg. Med. Chem. 2004, 12, 5579.
(5) Yin, J.; Xiang, B.; Huffman, M. A.; Raab, C. E.; Davies, I. W. J. Org.
Chem. 2007, 72, 4554.
(6) (a) Manley, P. J.; Bilodeau, M. T. Org. Lett. 2002, 4, 3127. For a similar
conversion of quinoline N-oxides, see: (b) Couturier, M.; Caron, L.; Tumidajski,
S.; Jones, K.; White, T. D. Org. Lett. 2006, 8, 1929.
(7) Keith, J. M. J. Org. Chem. 2006, 71, 9540.
(8) Keith, J. M. J. Org. Chem. 2008, 73, 327.
(9) (a) Andersson, H.; Almqvista, F.; Olsson, R. Org. Lett. 2007, 9, 1335.
(b) Andersson, H.; Wang, X.; Bjo¨rklund, M.; Olsson, R.; Almqvista, F.
Tetrahedron Lett. 2007, 48, 6941. (c) Chung, J. Y. L.; Cvetovich, R. J.;
McLaughlin, M.; Amato, J.; Tsay, F.-R.; Jensen, M.; Weissman, S.; Zewge, D.
J. Org. Chem. 2006, 71, 8602.
Iodo- or 2-bromopyridine N-oxides were readily magnesiated
with i-PrMgCl· LiCl via the iodine or bromine-magnesium
exchange. The bromine adjacent to pyridine N-oxide (at the
2- or 6-position) can be regioselectively magnesiated in the
presence of other position substituted halogens. This method
was tested in various substituted pyridine N-oxide systems,
and has been successfully applied to the total synthesis of
caerulomycins E and A.
(10) Raminelli, C.; Liu, Z.; Larock, R. C. J. Org. Chem. 2006, 71, 4689.
(11) (a) Campeau, L.-C.; Rousseaux, S.; Fagnou, K. J. Am. Chem. Soc. 2005,
127, 18020. (b) Leclerc, J.-P.; Fagnou, K. Angew. Chem., Int. Ed 2006, 45, 7781.
(c) Do, H.-Q.; Daugulis, O. J. Am. Chem. Soc. 2007, 129, 12404. (d) Kanyiva,
K. S.; Nakao, Y.; Hiyama, T. Angew. Chem., Int. Ed. 2007, 46, 8872. (e)
Campeau, L.-C.; Schipper, D. J.; Fagnou, K. J. Am. Chem. Soc. 2008, 130, 3266.
(f) Campeau, L.-C.; Me´gan, B.-L.; Leclerc, J.-P.; Villemure, E.; Gorelsky, S.;
Fagnou, K. J. Am. Chem. Soc. 2008, 130, 3276. (g) Cho, S. H.; Hwang, S. J.;
Chang, S. J. Am. Chem. Soc. 2008, 130, 9254. For a similar reaction of
N-iminopyridinium ylides, see: (h) Larive´e, A.; Mousseau, J. J.; Charette, A. B.
J. Am. Chem. Soc. 2008, 130, 52.
(12) For reviews, see: (a) Chinchilla, R.; Na´jera, C.; Yus, M. ARKIVOC 2007,
12, 152. (b) Mulvey, R.; Mongin, F.; Uchiyama, M.; Kondo, Y. Angew. Chem.,
Int. Ed. 2007, 46, 3802. (c) Schlosser, M.; Mongin, F. Chem. Soc. ReV. 2007,
36, 1161. (d) Mongin, F.; Que´guiner, G. Tetrahedron 2001, 57, 4059. For a
recent report, see: (e) Seggio, A.; Chevallier, F.; Vaultier, M.; Mongin, F. J.
Org. Chem. 2007, 72, 6602.
(13) (a) Denmark, S. E.; Fan, Y. Tetrahedron: Asymmetry 2006, 17, 687.
(b) Tre´court, F.; Gervais, B.; Mongin, O.; Gal, L. C.; Mongin, F.; Que´guiner,
G. J. Org. Chem. 1998, 63, 2892. (c) Mongin, O.; Rocca, P.; Dumont, L. T.;
Tre´court, F.; Marsais, F.; Godard, A.; Que´guiner, G. J. Chem. Soc., Perkin Trans.
1 1995, 2503. (d) Couture, A.; Huguerre, E.; Grandclaudon, P. Tetrahedron Lett.
1989, 30, 183. (e) Abramovitch, R. A.; Saha, M.; Smith, E. M.; Coutts, R. T.
J. Am. Chem. Soc. 1967, 89, 1537. For an example of lithiation of 2-bromopy-
ridine N-oxide through bromine-lithium exchange with n-BuLi, see: (f)
Takahashi, T.; Koga, H.; Sato, H.; Ishizawa, T.; Taka, N. Heterocycles 1995,
41, 2405. For an example of the lithiation of pyrazole N-oxide, see: (g) Paulson,
A. S.; Eskildsen, J.; Vedsø, P.; Begtrup, M. J. Org. Chem. 2002, 67, 3904.
(14) Hlavinka, M. L.; Hagadorn, J. R. Organometallics 2007, 26, 4105.
Pyridine N-oxide1 has received wide attention as a synthetic
intermediate, oxidant,2 catalyst, and ligand.3 In addition, some
of the related compounds are also of important biological or
pharmaceutical activities.4 Pyridine N-oxides have been utilized
as an important tool to functionalize the pyridine ring including
(1) (a) Katritzky, A. R.; Lagowski, J. M. Heterocyclic N-oxides; Methuen:
London, UK, 1967. (b) Albini, A.; Pietra, S. Heterocyclic N-oxides; CRC Press
Wolfe Publishing: London, UK, 1991. (c) Katritzky, A. R.; Lam, J. N.
Heterocycles 1992, 33, 1011. (d) Albini, A. Synthesis 1993, 263. (e) Youssif, S.
ARKIVOC 2001, 242 (i).
(2) Ito, R.; Umezawa, N.; Higuchi, T. J. Am. Chem. Soc. 2005, 127, 824,
and references cited therein.
(3) Chiral pyridine N-oxides and their analogues are useful catalysts or ligands
for asymmetric catalysis, for the most recent examples, see: (a) Malkov, A. V.;
Ram´ırez-Lo´pez, P.; Biedermannova´, L.; Dufkova´, L.; Kotora, M.; Zhu, F.;
Kocovsky´, P. J. Am. Chem. Soc. 2008, 130, 5341. (b) Chelucci, G.; Belmonte,
N.; Benaglia, M.; Pignataro, L. Tetrahedron Lett. 2007, 48, 4037. For reviews,
see: (c) Malkov, A. V.; Kocovsky´, P. Eur. J. Org. Chem. 2007, 29. (d) Kwong,
H. L.; Yeung, H. L.; Yeung, C. T.; Lee, W. S.; Lee, C. S.; Wong, W. L. Coord.
Chem. ReV. 2007, 251, 2188. (e) Chelucci, G.; Murineddu, G.; Pinna, G. A.
Tetrahedron: Asymmetry 2004, 15, 1373. (f) Malkov, A. V.; Kocovsky´, P. Curr.
Org. Chem. 2003, 7, 1737. (g) Chelucci, G.; Thummel, R. P. Chem. ReV. 2002,
102, 3129.
10.1021/jo802172f CCC: $40.75
Published on Web 12/04/2008
2009 American Chemical Society
J. Org. Chem. 2009, 74, 939–942 939